Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-29 · accession 0001048477-23-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-30 | 2023-06-29 | BMRN | Mueller Brian | EVP, CFO | F - Tax | $88.93 | -9,780 | 45.8K | -18% | -$869.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-29 | F | D | 4,602 | $88.93 | 50,983 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-29 | F | D | 4,602 | $88.93 | 46,381 | D | — | — | |
| 3 | Common | Common Stock | 2023-06-29 | F | D | 576 | $88.93 | 45,805 | D | — | — |